Exponent Inc

EXPO sits in an early Stage 1 consolidation after a clear momentum breakout above 63.59, signaling demand. Intermediate structure and mean‐reversion eligibility favor a bullish stance over the 1–3 month horizon, but short‐term overbought conditions and extension above the 9/21EMAs advise waiting for a pullback into the moving‐average zone before engaging.

• ↑Q1 revenue reached $166.3M (+14% YoY), net income $29.6M (+11%) and EBITDA $43.1M (+15%; 28.4% margin).
• ↑Returned capital with $79M in share repurchases and $16.6M dividends in Q1.
• ↓Shares trade at 25.5x P/E vs a fair 16.2x, suggesting overvaluation risk.